The world’s most lucrative healthcare market is quickly appreciating Aussie pharmaceuticals company Pharmaxis (ASX: PXS) whose cystic fibrosis (CF) treatment Bronchitol is rapidly emerging as the preferred treatment by CF sufferers in the United States. Researched and manufactured in Australia, Bronchitol gained commercial approval from the US Food and Drug Administration (FDA) in October 2020
Read More
Vowing to look after themselves better in the wake of a pandemic, Australians are keenly focused on their personal health and wellness as evidenced by allied healthcare services provider Healthia (ASX: HLA) which is expected to report more than an 86% increase in earnings. A market update was provided by Healthia which operates a network
Read More
With 13.2 million Australians suffering from long term eye problems, the rationale behind Healthia’s (ASX: HLA) $43m acquisition of The Optical Company was a logical opportunity to expand and investors have taken notice with HLA shares trading at all-time highs over the past month. While it may appeared a simple tack-on acquisition, such price movement
Read More
Aussie pharmaceuticals company Acrux (ASX: ACR) is quickly making inroads through the lucrative American healthcare system with regulatory approval granted for their generic equivalent of a common testosterone topical solution which generates more than $25 million annually. Approval was granted from the Food and Drug administration for Acrux’s gel following their submission in August 2018
Read More
Is the notion of the typical Australian stacking on the ‘isobars’ and indulging in a few too many ‘lockdown lagers’ during their in-house detention just another case of fake news? In reality, says Healthia (ASX: HLA) CEO Wesley Coote, incarcerated citizens were more likely to be exercising more often and assiduously holding to their appointments
Read More
Pediatric healthcare company Nutritional Growth Solutions (ASX: NGS) is set to significantly increase their exposure to the lucrative US healthcare products market, securing a distribution agreement that will see more than 1,000 sales representatives begin pushing NGS products. The agreement is with leading US medical distributor cooperative IMCO, INC which distributes healthcare products through home
Read More